BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 26056266)

  • 1. Glycosphingolipids are modulators of disease pathogenesis in amyotrophic lateral sclerosis.
    Dodge JC; Treleaven CM; Pacheco J; Cooper S; Bao C; Abraham M; Cromwell M; Sardi SP; Chuang WL; Sidman RL; Cheng SH; Shihabuddin LS
    Proc Natl Acad Sci U S A; 2015 Jun; 112(26):8100-5. PubMed ID: 26056266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid precursor protein (APP) contributes to pathology in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Bryson JB; Hobbs C; Parsons MJ; Bosch KD; Pandraud A; Walsh FS; Doherty P; Greensmith L
    Hum Mol Genet; 2012 Sep; 21(17):3871-82. PubMed ID: 22678056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of Abeta is associated with acceleration of onset of motor impairment and superoxide dismutase 1 aggregation in an amyotrophic lateral sclerosis mouse model.
    Li QX; Mok SS; Laughton KM; McLean CA; Volitakis I; Cherny RA; Cheung NS; White AR; Masters CL
    Aging Cell; 2006 Apr; 5(2):153-65. PubMed ID: 16626394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of β-Glucocerebrosidase Activity Preserves Motor Unit Integrity in a Mouse Model of Amyotrophic Lateral Sclerosis.
    Henriques A; Huebecker M; Blasco H; Keime C; Andres CR; Corcia P; Priestman DA; Platt FM; Spedding M; Loeffler JP
    Sci Rep; 2017 Jul; 7(1):5235. PubMed ID: 28701774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient.
    Niessen HG; Angenstein F; Sander K; Kunz WS; Teuchert M; Ludolph AC; Heinze HJ; Scheich H; Vielhaber S
    Exp Neurol; 2006 Oct; 201(2):293-300. PubMed ID: 16740261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J; Vannuvel K; Andries M; Waelkens E; Robberecht W; Van Den Bosch L
    J Neurochem; 2008 Sep; 106(5):2170-83. PubMed ID: 18624915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M; Giribaldi F; Melone M; Bonifacino T; Musante I; Carminati E; Rossi PI; Vergani L; Voci A; Conti F; Puliti A; Bonanno G
    Neurobiol Dis; 2014 Apr; 64():48-59. PubMed ID: 24361555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice.
    Sheean RK; Weston RH; Perera ND; D'Amico A; Nutt SL; Turner BJ
    J Neuroinflammation; 2015 Feb; 12():40. PubMed ID: 25889790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ablation of P2X7 receptor exacerbates gliosis and motoneuron death in the SOD1-G93A mouse model of amyotrophic lateral sclerosis.
    Apolloni S; Amadio S; Montilli C; Volonté C; D'Ambrosi N
    Hum Mol Genet; 2013 Oct; 22(20):4102-16. PubMed ID: 23736299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human Cu/Zn superoxide dismutase (SOD1) overexpression in mice causes mitochondrial vacuolization, axonal degeneration, and premature motoneuron death and accelerates motoneuron disease in mice expressing a familial amyotrophic lateral sclerosis mutant SOD1.
    Jaarsma D; Haasdijk ED; Grashorn JA; Hawkins R; van Duijn W; Verspaget HW; London J; Holstege JC
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):623-43. PubMed ID: 11114261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of human sporadic ALS biomarkers in the familial ALS transgenic mSOD1(G93A) mouse model.
    Lilo E; Wald-Altman S; Solmesky LJ; Ben Yaakov K; Gershoni-Emek N; Bulvik S; Kassis I; Karussis D; Perlson E; Weil M
    Hum Mol Genet; 2013 Dec; 22(23):4720-5. PubMed ID: 23836781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guanabenz delays the onset of disease symptoms, extends lifespan, improves motor performance and attenuates motor neuron loss in the SOD1 G93A mouse model of amyotrophic lateral sclerosis.
    Jiang HQ; Ren M; Jiang HZ; Wang J; Zhang J; Yin X; Wang SY; Qi Y; Wang XD; Feng HL
    Neuroscience; 2014 Sep; 277():132-8. PubMed ID: 24699224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ammonium tetrathiomolybdate delays onset, prolongs survival, and slows progression of disease in a mouse model for amyotrophic lateral sclerosis.
    Tokuda E; Ono S; Ishige K; Watanabe S; Okawa E; Ito Y; Suzuki T
    Exp Neurol; 2008 Sep; 213(1):122-8. PubMed ID: 18617166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GLT1 overexpression in SOD1(G93A) mouse cervical spinal cord does not preserve diaphragm function or extend disease.
    Li K; Hala TJ; Seetharam S; Poulsen DJ; Wright MC; Lepore AC
    Neurobiol Dis; 2015 Jun; 78():12-23. PubMed ID: 25818008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z; Sui Y; Gao W; Cai B; Fan D
    J Int Med Res; 2015 Feb; 43(1):67-79. PubMed ID: 25534414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E; Okawa E; Watanabe S; Ono S
    Hum Mol Genet; 2014 Mar; 23(5):1271-85. PubMed ID: 24163136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis.
    Stam NC; Nithianantharajah J; Howard ML; Atkin JD; Cheema SS; Hannan AJ
    Eur J Neurosci; 2008 Aug; 28(4):717-23. PubMed ID: 18702691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y; Guo Y; Wang X; Yu X; Duan W; Hong K; Wang J; Han H; Li C
    Neuroscience; 2015 Jul; 298():12-25. PubMed ID: 25841320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of mutant SOD1 on protein structure of skeletal muscle and spinal cord of familial amyotrophic lateral sclerosis: role of chaperone network.
    Wei R; Bhattacharya A; Hamilton RT; Jernigan AL; Chaudhuri AR
    Biochem Biophys Res Commun; 2013 Aug; 438(1):218-23. PubMed ID: 23886956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte loss of mutant SOD1 delays ALS disease onset and progression in G85R transgenic mice.
    Wang L; Gutmann DH; Roos RP
    Hum Mol Genet; 2011 Jan; 20(2):286-93. PubMed ID: 20962037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.